Adenosine and DuPont in vasodilator deal

DuPont (Wilmington, Del.) received a global license to develop and market ATL-146e and ATL-193 coronary vasodilators from Adenosine Therapeutics (Charlottesville, Va.), to diagnose and prognose corona...